Fertility-Sparing Management Using Progestin for Young Women with Endometrial Cancer From a Population-Based Study.

[1]  Donna D. Zhang,et al.  Mechanism of progestin resistance in endometrial precancer/cancer through Nrf2-AKR1C1 pathway , 2016, Oncotarget.

[2]  L. Chiva,et al.  Hysteroscopic surgery for conservative management in endometrial cancer: a review of the literature , 2015, Ecancermedicalscience.

[3]  V. Gebski,et al.  Improving treatment for obese women with early stage cancer of the uterus: rationale and design of the levonorgestrel intrauterine device ± metformin ± weight loss in endometrial cancer (feMME) trial. , 2014, Contemporary clinical trials.

[4]  K. Carson,et al.  Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review. , 2012, Gynecologic oncology.

[5]  E. Taioli,et al.  Endometrial hyperplasia, endometrial cancer and prevention: gaps in existing research of modifiable risk factors. , 2008, European journal of cancer.

[6]  Nahum Sonenberg,et al.  Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells. , 2006, Cancer research.

[7]  L. Akslen,et al.  Identification of high-risk patients by assessment of nuclear Ki-67 expression in a prospective study of endometrial carcinomas. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[8]  J. Wittliff,et al.  Tamoxifen and endometrial carcinoma: alterations in estrogen and progesterone receptors in untreated patients and combination hormonal therapy in advanced neoplasia. , 1984, American journal of obstetrics and gynecology.

[9]  R. M. Kelley,et al.  Progestational agents in the treatment of carcinoma of the endometrium. , 1961, The New England journal of medicine.

[10]  R. Dahiya,et al.  Progesterone receptor B gene inactivation and CpG hypermethylation in human uterine endometrial cancer. , 2001, Cancer research.

[11]  P. Satyaswaroop,et al.  Heterogeneity and progesterone‐receptor distribution in endometrial adenocarcinoma , 1984, Cancer.